Terns Pharmaceuticals, Inc. · NASDAQ:TERN

Orbimed Advisors LLC reported a 4.80% stake in Terns Pharmaceuticals, Inc. (Schedule 13D/A)

Event Nov 3, 2025 · Filed Nov 5, 2025

Orbimed Advisors LLC reported a 4.80% stake in Terns Pharmaceuticals, Inc., 4,240,068 shares, with active intent on Nov 3, 2025. Filed Nov 5, 2025 (Schedule 13D/A).

Stake
4.80%
Shares
4,240,068
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC4.80%4,240,068
ORBIMED CAPITAL GP VII LLC3.10%2,722,283
OrbiMed Asia GP III, L.P.1.20%1,061,075
OrbiMed Advisors III Ltd1.20%1,061,075
OrbiMed Genesis GP LLC0.50%456,710

Source

View original at SEC

Related